Medicines Australia Strategic Agreement is 'the end of the beginning'
Brendan Shaw Article published on 21 September 2021 in BioPharmaDispatch on the 2021 Strategic Agreement signed between the Australian...
Medicines Australia Strategic Agreement is 'the end of the beginning'
More risk for government this time around in agreement negotiation
COVID-19 vaccination a 12-month success for science, governments and industry
Space X and NASA: lessons on public-private R&D for the health debate
New industrial policy for biopharmaceutical and devices industry needs careful thought
HTA 2.0: time for a reboot
Crouching dragons and hidden tigers: the emergence of China’s life sciences sector
My failure as a Rockstar: lessons from technological change in the music industry
Universal health coverage and health technology assessment in Sub-Saharan Africa
To price or not to price, that is the question